Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 14Gastrointestinal 10Gynecologic 7Thoracic 4Genitourinary 4Dermatologic 3Head & Neck 2Endocrine 2CNS 2Other 1Lymphoid 1Classical hematology 1

Conditions

Brain Neoplasms 1050Glioblastoma 920Glioma 603Central Nervous System Neoplasms 436Astrocytoma 396Gliosarcoma 339Neuroblastoma 325Oligodendroglioma 255Neoplasms 181Medulloblastoma 165Breast Neoplasms 154Sarcoma 114Recurrence 108Ependymoma 105Neoplasm Metastasis 95Meningioma 91Melanoma 88Lymphoma 87Carcinoma, Non-Small-Cell Lung 87Lung Neoplasms 82Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Neurofibromatosis 1 79Wilms Tumor 75Osteosarcoma 69Head and Neck Neoplasms 69Ovarian Neoplasms 68Testicular Neoplasms 67Lymphoma, Non-Hodgkin 67Burkitt Lymphoma 66Familial ependymoma 63

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Behavior × CNS × Clear all
NCT03406208 2025-12-24

Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing

Massachusetts General Hospital

Phase NA Completed
228 enrolled
CNS

Schwannomatosis, Behavior, Neurofibromatosis 1, Neurofibromatosis 2, Neurofibromatoses

NCT01445314 2024-08-16

Analysis of Data Collected From Individuals Administered Neurobehavioral Assessments

National Institutes of Health Clinical Center (CC)

Completed
598 enrolled
CNS

Behavior, Brain Neoplasms, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡